Khwaja Abdul Rouf, Mushtaq Aamir, Mushtaq Younis, Hamid Arif, Mali Sajad, Parra Sajad, Mehdi Saqib, Islam Faheem Ul, Lateif Akil
Sher-i-Kashmir Institute of Medical Sciences (SKIMS), Main Road, Soura, Srinagar, Jammu and Kashmir, India.
J Kidney Cancer VHL. 2025 Apr 24;12(2):19-26. doi: 10.15586/jkc.v12i2.367. eCollection 2025.
To assess the surgical outcomes and techniques in managing renal cell carcinoma (RCC) with inferior vena cava (IVC) thrombus and bilateral renal tumors with a focus on the role of autotransplantation in complex cases, this retrospective study analyzed 58 patients treated at our center between 2013 and 2023 for RCC with tumor thrombus extending into the IVC and, in some cases, the right atrium (RA). Surgical management included radical nephrectomy and thrombectomy with techniques adapted to thrombus level. For level I and II thrombi, innovative occluding maneuvers were used to control the contralateral renal vein. For level IV thrombi, a beating heart technique combined with cardiopulmonary bypass (CPB) was employed. Of the 10 patients with bilateral renal tumors, 2 underwent autotransplantation and 8 underwent bilateral partial nephrectomy. In this 10-year retrospective study of 58 patients with either RCC with venous tumor extension or bilateral RCC, 40 males and 18 females, with a mean age of 66 ± 8 years. Tumor involvement was predominantly right-sided (72.4%). Thrombus levels included 53.44% Level I, 25.9% Level II, and 3.4% Level IV. Intraoperative and postoperative complications were minimal, affecting 10 patients; patients with Level I thrombus had a better survival rate; and one patient with Level IV thrombus died postoperatively. The mean blood loss was 360 mL and the mean operative time was 195 minutes. Histopathology revealed clear cell carcinoma in 65.5% of cases. Among the 10 patients with bilateral renal tumors, autotransplantation and partial nephrectomies resulted in excellent renal preservation and favorable outcomes. This study demonstrates the effectiveness of radical nephrectomy and thrombectomy for RCC with venous tumor extension. Tailored surgical techniques, including autotransplantation for bilateral tumors, resulted in excellent outcomes with minimal complications. Personalized surgical strategies were key to preserving renal function and improving survival in complex RCC cases.
为评估处理伴有下腔静脉(IVC)血栓的肾细胞癌(RCC)及双侧肾肿瘤的手术效果和技术,重点关注自体肾移植在复杂病例中的作用,本回顾性研究分析了2013年至2023年间在本中心接受治疗的58例患者,这些患者患有肿瘤血栓延伸至IVC甚至在某些情况下延伸至右心房(RA)的RCC。手术管理包括根治性肾切除术和血栓切除术,技术根据血栓水平进行调整。对于I级和II级血栓,采用创新的阻断操作来控制对侧肾静脉。对于IV级血栓,采用心脏跳动技术联合体外循环(CPB)。在10例双侧肾肿瘤患者中,2例接受了自体肾移植,8例接受了双侧部分肾切除术。在这项对58例伴有静脉肿瘤延伸的RCC或双侧RCC患者进行的10年回顾性研究中,男性40例,女性18例,平均年龄66±8岁。肿瘤累及主要为右侧(72.4%)。血栓水平包括53.44%为I级,25.9%为II级,3.4%为IV级。术中和术后并发症极少,影响了10例患者;I级血栓患者的生存率更高;1例IV级血栓患者术后死亡。平均失血量为360 mL,平均手术时间为195分钟。组织病理学显示65.5%的病例为透明细胞癌。在10例双侧肾肿瘤患者中,自体肾移植和部分肾切除术均实现了良好的肾功能保留和良好的预后。本研究证明了根治性肾切除术和血栓切除术治疗伴有静脉肿瘤延伸的RCC的有效性。量身定制的手术技术,包括对双侧肿瘤进行自体肾移植,带来了良好的预后且并发症极少。个性化的手术策略是在复杂RCC病例中保留肾功能和提高生存率的关键。